Wave Life Sciences Ltd. (WVE) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
WVE Revenue Analysis (2013–2024)
As of March 2, 2026, Wave Life Sciences Ltd. (WVE) generated trailing twelve-month (TTM) revenue of $109.2 million. The most recent quarter (Q3 2025) recorded $7.6 million in revenue, down 12.5% sequentially.
Looking at the longer-term picture, WVE's 5-year compound annual growth rate (CAGR) stands at +46.6%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $113.3 million in 2023.
When compared to Healthcare sector peers including ALNY (+65.2% YoY), IONS (+33.8% YoY), and ARWR (+4081.8% YoY). Compare WVE vs ALNY →
Peer Comparison
Compare WVE's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| WVECurrent | $109M | - | +46.6% | -101.9% | |
| ALNY | $3.7B | +65.2% | +49.8% | 13.5% | |
| IONS | $944M | +33.8% | +5.3% | -40.5% | |
| ARWR | $829M | +4081.8% | +56.6% | 11.9% | |
| CRSP | $4M | -81.7% | +37.3% | -18933.6% | |
| BEAM | $140M | +120.0% | +466.3% | -274.6% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $108.3M | -4.4% | $108.3M | 100.0% | $-110,403,000 | -101.9% |
| 2023 | $113.3M | +3005.1% | $113.3M | 100.0% | $-67,996,000 | -60.0% |
| 2022 | $3.6M | -91.1% | $3.6M | 100.0% | $-162,720,000 | -4459.3% |
| 2021 | $41.0M | +104.0% | $41.0M | 100.0% | $-127,016,000 | -310.1% |
| 2020 | $20.1M | +25.6% | $-110,867,000 | -552.2% | $-153,377,000 | -763.9% |
| 2019 | $16.0M | +10.9% | $-159,448,000 | -997.6% | $-208,317,000 | -1303.4% |
| 2018 | $14.4M | +289.1% | $-120,014,000 | -832.6% | $-159,523,000 | -1106.7% |
| 2017 | $3.7M | +149.4% | $-75,605,000 | -2041.2% | $-102,580,000 | -2769.4% |
| 2016 | $1.5M | +877.0% | $1.1M | 73.5% | $-55,327,000 | -3725.7% |
| 2015 | $152K | - | $-8,905,000 | -5858.6% | $-19,298,000 | -12696.1% |
See WVE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs WVE Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare WVE vs AGIO
See how WVE stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is WVE's revenue growth accelerating or slowing?
WVE TTM revenue: $109M. YoY growth: N/A. 5-year CAGR: +46.6%.
What is WVE's long-term revenue growth rate?
Wave Life Sciences Ltd.'s 5-year revenue CAGR of +46.6% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is WVE's revenue distributed by segment?
WVE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.